Harvard gets $5.6M to use organ-on-a-chip tech to test radiation sickness treatment
Developing medical countermeasures to deal with an unexpected nuclear event from a meltdown to terrorism is a significant area of interest for the U.S. Food and Drug Administration. But when it comes to developing treatments for radiation sickness from overexposure, it doesn’t exactly lend itself to human testing. Animals don’t offer an attractive alternative because […]
